Search
for

    Sort by

    Research 301–330 of 1000+

    1. Allelic frequencies for the seventeen Y-STR loci observed in Iraqi male patients with prostate cancer AFRICAN JOURNAL OF BIOTECHNOLOGY · 2015 · 3 citations
    2. Regarding prostate-specific antigen: let's not shoot the messenger QJM · 2011 · 3 citations
    3. Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride Cureus · 2025 · 2 citations
    4. Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats Frontiers in Pharmacology · 2025 · 2 citations
    5. Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases The World Journal of Men s Health · 2024 · 2 citations
    6. Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement Urology Annals · 2024 · 2 citations
    7. Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model Al Mustansiriyah Journal of Pharmaceutical Sciences · 2023 · 2 citations
    8. Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink European Urology · 2017 · 2 citations
    9. Effect of finasteride on prostate-specific antigen Lancet Oncology · 2006 · 2 citations
    10. Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese Human Genomics · 2024 · 1 citations
    11. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Curēus · 2023 · 1 citations
    12. Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study Scientific Reports · 2023 · 1 citations
    13. 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study British Journal of Clinical Pharmacology · 2022 · 1 citations
    14. Inhibition of Proliferation of LNCaP Prostate Cells by Corni Fructus Extract Is Associated with a Decrease in the Expression of Benign Prostatic Hyperplasia-Causing Factors Journal of Korean Medicine for Obesity Research · 2021 · 1 citations
    15. Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms Phytomedicine plus · 2021 · 1 citations
    16. A histological study of the effect of panax ginseng versus finasteride on induced benign prostatic hyperplasia in rats with potentiality of spontaneous recovery The Egyptian Journal of Histology · 2020 · 1 citations
    17. Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia Clinical Breast Cancer · 2019 · 1 citations
    18. The relation between androgenetic thin hair diagnosed by trichoscope and benign prostatic hyperplasia Journal of Cosmetic Dermatology · 2018 · 1 citations
    19. Male breast cancer after finasteride therapy for benign prostate hyperplasia Urological Science · 2013 · 1 citations
    20. Finasterid in der Behandlung der benignen Prostatahyperplasie Der Urologe · 2012 · 1 citations
    21. Acute prostatitis in german shepherds -a report of two cases INTAS POLIVET · 2010 · 1 citations
    22. Acción de Finasteride sobre el volumen prostático en caninos con hiperplasia prostática benigna El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · 2002 · 1 citations
    23. Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats Global Translational Medicine · 2026
    24. Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study Journal of the American Academy of Dermatology · 2026
    25. Modulation of AR-FGF-2-TGF beta Axis by Cosmos caudatus Suppresses Prostatic Epithelial Proliferation in a BPH Rat Model: A Comparative Study with Finasteride Journal of Multidisciplinary Applied Natural Science · 2026
    26. Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential Translational Andrology and Urology · 2026
    27. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026
    28. Reduced Prostate Cancer Risk in Patients with Androgenetic Alopecia Using 5-Alpha Reductase Inhibitors: A TriNetX Real-World Cohort Study Mendeley Data · 2026
    29. Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2026
    30. Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia Zenodo (CERN European Organization for Nuclear Research) · 2026